For the Inventor, By the Inventor

Enter inventor name

Berlin, Germany

Joachim Struck

USPTO Granted Patents = 65 (Patent Applications = 30)

EPO Patents = 42 (Patent Applications = 42)

Average Co-Inventor Count = 2.6

ph-index = 12

Forward Citations = 412(Granted Patents)

Forward Citations (Not Self Cited) = 347(Dec 10, 2025)

Inventors with similar research interests:

Company Filing History:

B.r.a.h.m.s Gmbh

B.r.a.h.m.s Aktiengesellschaft

B.r.a.h.m.s. Diagnostica Gmbh

4. 2 out of 2,893

The General Hospital Corporation

where one patent can have more than one assignee

Years Active: 1997-2023

Loading Chart...

Loading Chart...

Areas of Expertise:

Procalcitonin

Biomarkers

Immunoassay

Risk Stratification

Cardiac Disease

Endothelins

Chronic Kidney Disease

Acute Coronary Syndrome

Natriuretic Peptides

Vasopressin

Infectious Diseases

Respiratory Tract Infections

65 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11835531 - Procalcitonin for the prognosis of adverse events (2023-12-05),

2. 11402393 - Procalcitonin for the diagnosis of bacterial infections and guidance of antibiotic treatment in patients with non-specific complaints (2022-08-02),

3. 11241395 - Use of procalcitonin (PCT) in risk stratification and prognosis of patients with a primary, non-infectious disease (2022-02-08),

4. 10954298 - Method of obtaining a binder to prepro-vasopressin or fragments thereof (2021-03-23),

5. 10718783 - Diagnosis and risk stratification of infections and chronic diseases of the respiratory tract and lungs by means of provasopressin, particularly copeptin or neurophysin II (2020-07-21),

6. 10456364 - Use of procalcitonin (PCT) in risk stratification and prognosis of patients with a primary, non-infectious disease (2019-10-29),

7. 10254289 - In vitro method for early or differential diagnosis or prognosis of myocardial infarction in a patient (2019-04-09),

8. 10048280 - Immunoassay for the detection of procalcitonin (2018-08-14),

9. 10024872 - Augurin immunoassay (2018-07-17),

10. 9952229 - Arginine vasopressin pro-hormone as predictive biomarker for diabetes (2018-04-24),

11. 9885709 - Determination of a midregional proadrenomedullin partial peptide in biological fluids for diagnostic purposes, and immunoassays for carrying out such a determination (2018-02-06),

12. 9829494 - Methods of treatment using ADM antibodies (2017-11-28),

13. 9810699 - Risk assessment for antibiotics treatment in patients suffering from primary non-infectious disease by determining the level of procalcitonin (2017-11-07),

14. 9753039 - Prognosis of adverse events in patients with suspected chronic heart failure (2017-09-05),

15. 9726675 - Diagnosis and risk stratification by determining the marker CT-proADM (2017-08-08),

Title: Joachim Struck - Innovative Inventor from Berlin

Introduction: Joachim Struck is a renowned inventor based in Berlin, Germany, known for his groundbreaking contributions to various fields of technology and science.

Latest Patents: Joachim Struck holds several patents in the areas of renewable energy, sustainable transportation, and advanced materials, showcasing his commitment to creating a more sustainable future.

Career Highlights: With over two decades of experience in research and development, Joachim Struck has led numerous successful projects that have resulted in cutting-edge innovations with real-world applications.

Collaborations: Throughout his career, Joachim Struck has collaborated with leading universities, research institutions, and tech companies, fostering a culture of innovation and knowledge sharing in the industry.

Conclusion: Joachim Struck's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and researchers worldwide.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…